Translational Process

Overview

Journal J Transl Med

Publisher Biomed Central

Specialties Biomedical Engineering
General Medicine

Date 2023 Sep 28

PMID 37770943

Authors

Marina Boccardi

Affiliations

Soon will be listed here.

Citing Articles

Why should academia care about the Target Product Profile?.

Boccardi M, Gold M, Mahant V, Marincola F, Gunn A J Transl Med. 2024; 22(1):716.

PMID: 39095839 PMC: 11295361. DOI: 10.1186/s12967-024-05520-0.

Facilitating the use of the target product profile in academic research: a systematic review.

Ibnidris A, Liaskos N, Eldem E, Gunn A, Streffer J, Gold M J Transl Med. 2024; 22(1):693.

PMID: 39075460 PMC: 11288132. DOI: 10.1186/s12967-024-05476-1.

References

Zimmern R, Kroese M . The evaluation of genetic tests. J Public Health (Oxf). 2007; 29(3):246-50. DOI: 10.1093/pubmed/fdm028. View

Waldman S, Terzic A . Clinical and translational science: from bench-bedside to global village. Clin Transl Sci. 2010; 3(5):254-7. PMC: 5439613. DOI: 10.1111/j.1752-8062.2010.00227.x. View

Huddy J, Ni M, Misra S, Mavroveli S, Barlow J, Hanna G . Development of the Point-of-Care Key Evidence Tool (POCKET): a checklist for multi-dimensional evidence generation in point-of-care tests. Clin Chem Lab Med. 2018; 57(6):845-855. DOI: 10.1515/cclm-2018-1089. View

Mahant V . Translational medicines "Ecosystem". J Transl Med. 2020; 18(1):158. PMC: 7137407. DOI: 10.1186/s12967-020-02325-9. View

Lijmer J, Leeflang M, Bossuyt P . Proposals for a phased evaluation of medical tests. Med Decis Making. 2009; 29(5):E13-21. DOI: 10.1177/0272989X09336144. View

Boccardi M, Handels R, Gold M, Grazia A, Lutz M, Martin M . Clinical research in dementia: A perspective on implementing innovation. Alzheimers Dement. 2022; 18(11):2352-2367. DOI: 10.1002/alz.12622. View

Boccardi M, Festari C, Altomare D, Gandolfo F, Orini S, Nobili F . Assessing FDG-PET diagnostic accuracy studies to develop recommendations for clinical use in dementia. Eur J Nucl Med Mol Imaging. 2018; 45(9):1470-1486. DOI: 10.1007/s00259-018-4024-1. View

Whiting P, Rutjes A, Reitsma J, Glas A, Bossuyt P, Kleijnen J . Sources of variation and bias in studies of diagnostic accuracy: a systematic review. Ann Intern Med. 2004; 140(3):189-202. DOI: 10.7326/0003-4819-140-3-200402030-00010. View

Garner J . The significance of meaning: why do over 90% of behavioral neuroscience results fail to translate to humans, and what can we do to fix it?. ILAR J. 2014; 55(3):438-56. PMC: 4342719. DOI: 10.1093/ilar/ilu047. View

10.

Drucker E, Krapfenbauer K . Pitfalls and limitations in translation from biomarker discovery to clinical utility in predictive and personalised medicine. EPMA J. 2013; 4(1):7. PMC: 3599714. DOI: 10.1186/1878-5085-4-7. View

11.

Smailagic N, Vacante M, Hyde C, Martin S, Ukoumunne O, Sachpekidis C . ¹⁸F-FDG PET for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI). Cochrane Database Syst Rev. 2015; 1:CD010632. PMC: 7081123. DOI: 10.1002/14651858.CD010632.pub2. View

12.

Frisoni G, Boccardi M, Barkhof F, Blennow K, Cappa S, Chiotis K . Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers. Lancet Neurol. 2017; 16(8):661-676. DOI: 10.1016/S1474-4422(17)30159-X. View

13.

Bakker E, Hendrikse N, Ehmann F, van der Meer D, Llinares Garcia J, Vetter T . Biomarker Qualification at the European Medicines Agency: A Review of Biomarker Qualification Procedures From 2008 to 2020. Clin Pharmacol Ther. 2022; 112(1):69-80. PMC: 9313861. DOI: 10.1002/cpt.2554. View